XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Derivatives | 3 Months Ended
--- | ---
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivatives | DERIVATIVES Interest Rate Derivative Instrument In June 2021, the Company entered into an interest rate swap agreement for a notional amount of $300.0 million, effective June 28, 2021, with an expiration date of May 28, 2026, which hedges the floating LIBOR on a portion of the term loan (Term Loan A, $1.10 billion balance) under the Credit Agreement to a fixed rate of 0.986%. The Company elected to designate this interest rate swap as a cash flow hedge for accounting purposes. As this cash flow hedge is considered effective, any future gains and losses are reflected within Accumulated Other Comprehensive Income in the Consolidated Statements of Comprehensive Income. Derivatives in a net asset position are recorded in "Prepaid expenses and other current assets" on our Consolidated Balance Sheets and derivatives in a net liability position are recorded in "Other current liabilities" on our Consolidated Balance Sheets. No ineffectiveness was recorded on this contract during the three months ended December 31, 2021.
Table 8.1: Details of Derivatives Fair Value
| December 31, 2021 |  | September 30, 2021
| (in thousands)
Assets: |  |  |
Interest rate swap | $ | 3,233 |  |  | $ | — |
Total assets | $ | 3,233 |  |  | $ | — |
Liabilities: |  |  |
Interest rate swap | $ | — |  |  | $ | 410 |
Total liabilities | $ | — |  |  | $ | 410 |
Table 8.2: Gains on Derivatives
| For the Three Months Ended
| December 31, 2021 |  | December 31, 2020
| (in thousands)
Net gains recognized in AOCI on derivatives, net of tax (1) | $ | 2,177 |  |  | $ | — |
Amounts reclassified to earnings from accumulated other comprehensive loss (2) | 508 |  |  | — |
Net current period other comprehensive income | $ | 2,685 |  |  | $ | — |
(1)Amount is net of tax expense of $0.8 million for the three months ended December 31, 2021. (2)Amount is net of tax benefit for $0.2 million for the three months ended December 31, 2021. Counterparty Risk The Company is exposed to credit losses in the event of nonperformance by the counterparty to our derivative instrument. Our counterparty has investment grade credit ratings; accordingly, we anticipate that the counterparty will be able to fully satisfy its obligations under the contracts. Our agreements outline the conditions upon which it or the counterparty are required to post collateral. As of December 31, 2021, there was no collateral posted with its counterparty related to the derivatives.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 5 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration